Go to the list of all blogs
M. Benett's Avatar
published in Blogs
Aug 20, 2026
United States Antimony (UAMY) Flat Over 30 Days: Revenue -25% Drop and +10% Buyback Rally

United States Antimony (UAMY) Flat Over 30 Days: Revenue -25% Drop and +10% Buyback Rally

Key Takeaways

  • UAMY shares are roughly flat over the trailing 30 days, edging lower by about 2%, but that masks sharp intra-period swings tied to second-quarter results and a share-buyback announcement.
  • Second-quarter revenue fell 25% year over year to $7.9 million as antimony selling prices declined about 52%, prompting management to lower its full-year 2026 revenue outlook.
  • The board authorized a $100 million share repurchase program and called the stock undervalued, helping shares rally roughly 10% on the news.
  • Zeolite revenue more than doubled, and Defense Logistics Agency (DLA) shipments are ramping, supporting a longer-term growth narrative.

Current Market Snapshot

United States Antimony Corporation (UAMY) traded near $5.73 in its most recent session, leaving shares essentially flat on a trailing 30-day basis after a period of unusually high volatility. The relative calm in the headline figure conceals a turbulent stretch: the stock dropped roughly 24% in a single session after second-quarter results disappointed, then partially recovered before surging about 10% when management unveiled a $100 million repurchase authorization.

From what I see, the stock sits within the critical-minerals complex, where investors are weighing a sharp decline in antimony pricing against the company's progress in building domestic supply chains, expanding zeolite output, and fulfilling government contracts. Sentiment remains split between near-term pricing pressure and the longer-term strategic value of being the only fully integrated antimony producer outside of China and Russia. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

A Closer Look at UAMY's Business and Competitive Position

United States Antimony Corporation produces and processes antimony, zeolite, and precious metals, operating facilities in Montana and Mexico and the Bear River Zeolite site in Idaho. The company markets antimony oxide, antimony metal, and antimony trisulfide for applications spanning flame retardants, batteries, bearings, and ammunition primers, while its zeolite products serve water filtration, environmental remediation, odor control, and animal nutrition markets. It also recovers gold and silver from third-party ore at its Montana facility.

A key competitive distinction is integration: UAMY describes itself as the only fully integrated antimony company in the world outside of China and Russia. Recent acquisitions of mining claims and leases in Alaska, Montana, and Ontario, Canada, are aimed at reducing reliance on third-party antimony ore and expanding the company's in-house supply chain. Investors follow the stock closely because of its exposure to a strategically important mineral with limited Western production capacity. To put the competitive landscape in context, I reviewed similar names through Tickeron’s AI Pattern Search Engine.

Recent Catalysts Driving the Stock

The dominant catalyst in recent weeks was the company's second-quarter report. Revenue declined 25% year over year to $7.9 million, well below analyst estimates, as a 26% increase in antimony pounds sold was more than offset by a roughly 52% decline in average selling prices to $13.70 per pound. Management responded by lowering 2026 revenue guidance to a range of $60 million to $75 million, down from a prior target of $125 million, citing the steep drop in antimony spot prices.

H.C. Wainwright maintained a Buy rating on the stock while trimming its price target to $9.25 from $11.75, citing balance-sheet strength and growth potential in the zeolite business. Zeolite revenue more than doubled to $1.9 million, driven by cattle-nutrition demand and broader distribution. Separately, the company reported its first DLA shipments of roughly 82,000 pounds against approximately $57 million in cumulative orders, with additional deliveries expected to contribute to third- and fourth-quarter revenue.

The most recent positive catalyst came when the board authorized a repurchase program of up to $100 million of common stock. Chairman and CEO Gary Evans said the board determined the shares were undervalued after reviewing projects across the U.S., Canada, and Mexico, a signal that helped the stock rebound by roughly 10% in a single session.

2026 Outlook and What Investors Should Watch

Looking ahead, the trajectory of antimony pricing remains the single most important variable for UAMY, given its direct effect on revenue and margins. Management has indicated it expects prices to stay near recent depressed levels, so execution on volume growth and cost discipline will be central to the 2026 story. Investors will also monitor progress toward a stated milestone: the company projects that 2026 will be the first year it begins using ore mined from its own operations to fulfill contracted customer needs, a shift executives say should improve margins and supply certainty.

Other factors to watch include the pace of DLA deliveries against the company's cumulative orders, the ramp-up of the Thompson Falls smelter expansion in Montana, and continued growth in the zeolite segment. Balance-sheet liquidity, reported at roughly $62 million in cash and U.S. Treasuries, provides a cushion, but the company remains unprofitable and reported negative operating cash flow in the first half of 2026. Commodity-price risk, government policy toward critical minerals, and execution on capital-intensive projects represent the key uncertainties heading into the remainder of the year.

Exploring Tickeron AI Tools for Trading Ideas

In my research process, I frequently turn to Tickeron’s Trending AI Robots page to review curated selections of AI-driven trading bots. It highlights top-performing and relevant strategies for stocks like UAMY, spanning short-term momentum models to longer-horizon trend-following systems. This helps me compare methodologies and identify approaches that align with current market conditions before committing capital.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: UAMY

UAMY in -25.49% downward trend, declining for three consecutive days on August 12, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where UAMY declined for three days, in of 340 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

UAMY moved below its 50-day moving average on August 10, 2026 date and that indicates a change from an upward trend to a downward trend.

UAMY broke above its upper Bollinger Band on August 07, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for UAMY entered a downward trend on September 08, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 63 cases where UAMY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on September 08, 2026. You may want to consider a long position or call options on UAMY as a result. In of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for UAMY just turned positive on September 03, 2026. Looking at past instances where UAMY's MACD turned positive, the stock continued to rise in of 53 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where UAMY advanced for three days, in of 259 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. UAMY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UAMY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.498) is normal, around the industry mean (7.366). P/E Ratio (0.000) is within average values for comparable stocks, (122.967). UAMY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (0.293). UAMY has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.031). P/S Ratio (20.576) is also within normal values, averaging (287.376).

Notable companies

The most notable companies in this group are BHP Group Limited (NYSE:BHP), Vale SA (NYSE:VALE).

Industry description

The category includes companies that explore for, mine and extract metals, such as copper, diamonds, nickel, cobalt ore, lead, zinc and uranium. BHP, Rio Tinto and Southern Copper Corporation are major players in this space.

Market Cap

The average market capitalization across the Other Metals/Minerals Industry is 9.49B. The market cap for tickers in the group ranges from 230 to 229.1B. BHP holds the highest valuation in this group at 229.1B. The lowest valued company is BAJFF at 230.

High and low price notable news

The average weekly price growth across all stocks in the Other Metals/Minerals Industry was -1%. For the same Industry, the average monthly price growth was -2%, and the average quarterly price growth was -11%. NVA experienced the highest price growth at 25%, while XPL experienced the biggest fall at -17%.

Volume

The average weekly volume growth across all stocks in the Other Metals/Minerals Industry was 12%. For the same stocks of the Industry, the average monthly volume growth was -57% and the average quarterly volume growth was -28%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 59
P/E Growth Rating: 75
Price Growth Rating: 55
SMR Rating: 91
Profit Risk Rating: 86
Seasonality Score: 13 (-100 ... +100)
View a ticker or compare two or three
UAMY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a producer of antimony products

Industry OtherMetalsMinerals

Profile
Details
Industry
Metal Fabrication
Address
4438 W. Lovers Lane
Phone
+1 406 606-4117
Employees
101
Web
https://www.usantimony.com
Interact to see
Advertisement
Shares of CRDO surged +11.90% on March 5, 2026, closing at $114.74 versus a prior close of $102.54. Primary catalyst: Strong Q3 fiscal 2026 earnings reported on March 2, with revenue of $407 million beating consensus estimates by more than $19 million and non-GAAP EPS of $1.07 surpassing forecasts by $0.29.
SPY is trading down approximately -1.30% in Friday premarket, slipping from the prior session's close of $681.31 to around $677–$678. The primary catalyst is a sharply negative February 2026 Nonfarm Payrolls report, which showed a decline of 92,000 jobs — a massive miss versus the consensus forecast of +50,000.
WAL shares dropped approximately 12% in early trading on March 6, 2026, from a prior close of ~$80.74 to roughly ~$71, marking one of the stock's sharpest single-session declines in recent months. The primary catalyst was a surprise announcement that Jefferies Financial Group declined to make a $126.4 million payment owed to Western Alliance Bank under a forbearance agreement tied to the LAM Trade Finance loan portfolio.
MRVL shares surged approximately +15% at the open on March 6, 2026, after closing at $75.68 the prior session. The primary catalyst was a strong Q4 fiscal 2026 earnings report released after the close on March 5, with non-GAAP EPS of $0.80 beating the $0.79 consensus estimate and revenue of $2.219 billion exceeding expectations.
Shares of Day One Biopharmaceuticals surged approximately +65.57% on March 6, 2026, rising from a prior close of $12.78 to an intraday price around $21.16. The primary catalyst driving the session's gains is acquisition and takeover speculation, with reports circulating that Day One may be a buyout target.
GAP shares fell approximately 13% in early trading on March 6, 2026, following the company's Q4 fiscal 2025 earnings report released after market close on March 5. Gap met Wall Street's Q4 estimates on both earnings per share and revenue, but fiscal 2026 guidance fell short of analyst expectations.
Shares of Red Cat Holdings surged approximately +22% in early Friday trading on March 6, 2026, building on a powerful week of momentum in defense drone stocks. The primary catalyst is escalating geopolitical conflict — U.S. and Israeli military strikes on Iran, which dramatically boosted investor appetite for domestic drone and defense technology companies.
The primary catalyst for the decline was the pricing of a secondary offering of roughly 9 million shares at about 22.25 dollars per share by Ingram Holdco, an affiliate of Platinum Equity, with all proceeds going to the selling shareholder and not to Ingram Micro itself. Investors often view such secondary offerings as short‑term bearish because they increase the freely tradable float and signal that a major holder is cashing out part of its stake, even if the company’s operations remain intact.
Rumble reported Q4 2025 revenue of about 27.1 million dollars, below consensus expectations near 29 million dollars and down roughly 10% year over year, confirming that top‑line momentum has stalled. GAAP EPS came in at a loss of around 0.13 dollars, missing analyst estimates by roughly 0.05 dollars and underscoring that the platform remains far from break‑even despite prior cost cuts and efficiency efforts.
Tronox’s Q4 2025 non‑GAAP EPS came in at a loss of about 0.60 dollars, missing expectations by roughly 0.02 dollars, while revenue of around 730 million dollars grew about 8% year over year, showing volume resilience but weak earnings power.
Defense budgets worldwide are surging — global military spending topped $2.2 trillion in 2023, a record high — while semiconductor demand is projected to reach a $1 trillion industry by 2030. At the intersection of these two mega-trends sits one of Tickeron's most strategically focused AI Trading Robots: the XAR, ITA, SOXL – AI Trading Agent (3 Tickers), 15min.
HIMS shares surged approximately +43.85% in premarket trading on Monday, March 9, 2026, rising from a prior close of $15.74 to around $22.80. Primary catalyst: Novo Nordisk officially ended its patent infringement lawsuit against Hims & Hers and announced a landmark partnership to distribute branded Wegovy through the Hims platform at $599/month.
XENE shares surged approximately +45.93% in premarket trading on March 9, 2026, one of the largest single-session moves in the company's history. The primary catalyst: Xenon announced positive topline Phase 3 X-TOLE2 results for its lead drug candidate azetukalner in focal onset seizures (FOS), meeting the primary endpoint with overwhelming statistical significance.
Shares of OLMA dropped approximately 41% in Monday's session, one of the steepest single-day declines in the company's history. The primary catalyst was Roche's Phase 3 persevERA trial failure — a late-stage study of giredestrant, a closely competing selective estrogen receptor degrader (SERD), which missed its primary endpoint of statistically significant improvement in progression-free survival.
RLMD shares surged approximately +40% at the open on March 9, 2026, rising from a prior close of $4.45 to approximately $6.23, driven by a major clinical trial readout. The primary catalyst was the announcement of 12-month interim data from the Phase 2 trial of NDV-01, Relmada's lead oncology candidate, in patients with high-risk non-muscle invasive bladder cancer (NMIBC) — results that significantly exceeded historical benchmarks.
CRCL surged +8.66% on Monday, March 9, 2026, rising from a prior close of $101.94 to trade at $110.77 intraday. The primary catalyst is a landmark stablecoin milestone: Circle's USDC overtook Tether as the dominant stablecoin by transfer volume, accounting for approximately 70% of all stablecoin transfer activity as total stablecoin transfers hit $1.8 trillion in February.
Carnival Corporation (CCL) shares fell approximately -7.60% in Monday's session, dropping from a Friday close of $25.79 to around $23.83. The primary catalyst is a broad market sell-off driven by intensifying recession fears, with the S&P 500 and consumer discretionary names bearing the brunt of the pressure.
Shares of Bloom Energy (BE) are surging approximately +10.30% in Monday's session, rebounding sharply from a steep -15.50% selloff on Friday, March 6, 2026. Friday's decline was triggered by an Oracle-OpenAI data center project update that spooked energy infrastructure investors; Monday's move reflects aggressive dip-buying and a sentiment reset.
IGV has rallied about 8–9% in the last 6 trading days, while SOXX has dropped about 8%, giving software a +16.6 percentage‑point edge—the largest 6‑day software‑over‑semi outperformance ever.[barchart]​ This comes right after software lagged semis by almost −15 percentage points into late January, the widest gap since 2008, and as hedge‑fund short exposure to U.S. software and services hit a record ~3.8% of market cap.
Crude’s explosive war‑driven spike faded on March 9 because the market suddenly started to price less extreme, shorter‑lived supply risk and more policy intervention, not a multi‑month shortage. WTI, which had briefly traded above 115–120 dollars on Iran‑war headlines and Strait of Hormuz fears, slid back toward the high‑80s as traders digested G7 reserve‑release talk, Trump’s comments about a “brief” war, and the reality that prices had run far ahead of fundamentals.